https://www.selleckchem.com/products/10058-f4.html
alassemia. The results of this study provide a data basis for clinical laboratories and a reliable reference for clinical consultation. Cecal adenocarcinoma has a high degree of malignancy and poor prognosis, thereby bringing serious disease burden to patients. The long-term survival rate of patients with cecal adenocarcinoma deserves us to explore more deeply. In addition, appropriate methods that evaluate the survival outcome of cecal adenocarcinoma are few. This study used the data provided by the Surveillance, Epidemiology, and End
Like
Comment
Share
